Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
As of close of business last night, Beam Therapeutics Inc’s stock clocked out at $21.46, up 5.71% from its previous closing price of $20.3. In other words, the price has increased by $5.71 from its previous closing price. On the day, 3.95 million shares were traded. BEAM stock price reached its highest trading level at $22.39 during the session, while it also had its lowest trading level at $20.8575.
Ratios:
To gain a deeper understanding of BEAM’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.81 and its Current Ratio is at 8.81. In the meantime, Its Debt-to-Equity ratio is 0.14 whereas as Long-Term Debt/Eq ratio is at 0.13.
On March 10, 2025, Scotiabank Upgraded its rating to Sector Outperform which previously was Sector Perform but kept the price unchanged to $40.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jul 03 ’25 when Simon Amy sold 876 shares for $20.12 per share. The transaction valued at 17,625 led to the insider holds 64,864 shares of the business.
Simon Amy sold 374 shares of BEAM for $6,336 on Jul 01 ’25. The Chief Medical Officer now owns 65,740 shares after completing the transaction at $16.94 per share. On Apr 01 ’25, another insider, Bellon Christine, who serves as the Chief Legal Officer of the company, sold 5,674 shares for $18.35 each. As a result, the insider received 104,122 and left with 117,294 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BEAM now has a Market Capitalization of 2157953024 and an Enterprise Value of 596417408. For the stock, the TTM Price-to-Sale (P/S) ratio is 33.94 while its Price-to-Book (P/B) ratio in mrq is 1.92. Its current Enterprise Value per Revenue stands at 9.381 whereas that against EBITDA is -1.459.
Stock Price History:
The Beta on a monthly basis for BEAM is 2.20, which has changed by -0.17078823 over the last 52 weeks, in comparison to a change of 0.12153554 over the same period for the S&P500. Over the past 52 weeks, BEAM has reached a high of $35.25, while it has fallen to a 52-week low of $13.52. The 50-Day Moving Average of the stock is 20.69%, while the 200-Day Moving Average is calculated to be -6.77%.
Shares Statistics:
It appears that BEAM traded 2.07M shares on average per day over the past three months and 2565210 shares per day over the past ten days. A total of 100.56M shares are outstanding, with a floating share count of 89.78M. Insiders hold about 10.71% of the company’s shares, while institutions hold 88.21% stake in the company. Shares short for BEAM as of 1749772800 were 21731372 with a Short Ratio of 10.49, compared to 1747267200 on 20844838. Therefore, it implies a Short% of Shares Outstanding of 21731372 and a Short% of Float of 24.299999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
